Legal Issues

U.S. patent issued for high throughput gene expression analysis

Published in Gene Therapy Weekly, October 16th, 2003

Althea Technologies, Inc., a provider of gene-based manufacturing and testing services to accelerate drug development, announced that it has been granted U.S. Patent number 6,618,679 covering its eXpress Profiling technology.

The patent entitled "Methods for Analysis of Gene Expression" represents the first to issue of a series of applications related to Althea's novel approach to high throughput gene expression analysis.

"We are very pleased to have been granted this patent," stated Joseph Monforte, VP and chief scientific officer of Althea, and a key inventor of the eXpress Profiling technology. "We believe that eXpress Profiling offers a powerful...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-10-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry